Baxter International

Selected news for the capital firm - Baxter International, collected since 10/2017. Recent stories appear in globalbankingandfinance.com and Zacks. This capital firm shares healthcare news with Medtronic, COVID-19, Abbott Laboratories, Pfizer, Fresenius Medical Care and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/23/2021 Continuous Renal Replacement Therapy Market 2021: SWOT Analysis, Share, Trends, and Overview 2021-2027 | Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG & so on… globalbankingandfinance.com Continuous Renal Replacement Therapy Market 2021: SWOT Analysis, Share, Trends, and Overview 2021-2027 Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG & so on…Published linker 5 A recent market study published by Future Market Insights (FMI) – " Continuous Renal Replacement Therapy Market: Global Industry Analysis & Opportunity Assessment 2017-2027 " consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on ...
4/22/2021 Baxter International (BAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - April 22, 2021 - Zacks.com Zacks Baxter International ( BAX Quick Quote BAX - Free Report ) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2021. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report ...
4/21/2021 Other news to note for April 21, 2021 | 21 BioWorld Deerfield, Ill.-based Baxter International Inc. received a new research and development grant from the German Federal Ministry of Education and Research. With the grant, Baxter will lead an initiative aiming to create a new technology platform enhancing the ability to target selective removal of pathogenic substances during certain extracorporeal blood purification therapies. The grant provides €1.5 million in funding over three years to Baxter and its research partners ...
4/18/2021 Informe de investigación de mercado global Tratamiento de la infección por Clostridium difficile 2021 – Incrementos de ventas por crecimiento de ingresos | Merck, Baxter International, Sanofi teknlifenews.com ... análisis completo del mercado segmentado por tipo, aplicaciones y geografías. El informe de mercado global de Clostridium Difficile Infection Treatment también incluye una consideración de los proveedores clave como Merck, Baxter International, Sanofi, Pfizer, Novartis, Astellas Pharma, Eli Lilly, AstraZeneca, Actelion Pharmaceuticals, Mylan que operan en el mercado y un comentario sobre las carteras de productos de los proveedores.Las regiones importantes del mercado de Clostridium ...
4/11/2021 Baxter International Inc. (NYSE:BAX) Position Increased by Home Federal Bank of Tennessee thelincolnianonline.com Baxter International Inc. (NYSE:BAX) Position Increased by Home Federal Bank of Tennessee Posted by Alanna Baker on Apr 11th, 2021 TweetHome Federal Bank of Tennessee increased its stake in Baxter International Inc. (NYSE:BAX) by 2.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,535 shares of the medical instruments supplier’s stock ...
4/11/2021 Home Federal Bank of Tennessee Boosts Position in Baxter International Inc. (NYSE:BAX) com-unik.info Home Federal Bank of Tennessee Boosts Position in Baxter International Inc. (NYSE:BAX) Posted by Eileen French on Apr 11th, 2021Home Federal Bank of Tennessee boosted its stake in Baxter International Inc. (NYSE:BAX) by 2.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,535 shares of the medical instruments supplier’s stock after buying ...
4/9/2021 2021-2030 Report on Global Clostridium Difficile Treatment Market by Player, Region, Type, Application and Sales Channel reportsnreports.com ... It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Clostridium Difficile Treatment market. Leading players of Clostridium Difficile Treatment including: - Actelion Pharmaceuticals - Astellas Pharma - AstraZeneca - Bausch Health - Baxter International - CRESTOVO - Da Volterra - Eli Lilly - Finch Therapeutics Group - Immuron - Merck - MGB Biopharma - Mylan - Novartis - Otsuka Pharmaceutical - Pfizer - Rebiotix - Romark Laboratories - Sanofi - Seres Therapeutics - Summit Therapeutics - Synthetic Biologics - Takeda - Valeant Pharmaceuticals - Valneva Market split by ...
4/8/2021 Global Artificial Organ and Bionics Market (2020 to 2025) - by Type, Technology, End-user and Geography - ResearchAndMarkets.com | Business Wire Business Wire ... Heart Gmbh Biomet, Inc Boston Scientific Corporation Edward Lifesciences Corporation Ekso Bionics Heartware International, Inc Iwalk, Inc. Jarvik Heart, Inc. SynCardia Systems, LLC Gambro AB Orthofix Holdings LifeNet Health Sonova BionX Medical Technologies Cochlear Baxter International SynCardia Berlin Heart GmbH Nipro Corporation Ottobock Recent Developments1. In February 2020, Ekso Bionics Holdings, Inc. collaborated with Kindred Healthcare, LLC to pilot EksoNR - a robotic exoskeleton, in their long-term acute care ...
4/8/2021 Global Artificial Organ and Bionics Market (2020 to 2025) – by Type, Technology, End-user and Geography – ResearchAndMarkets.com financialbuzz.com ... Heart Gmbh Biomet, Inc Boston Scientific Corporation Edward Lifesciences Corporation Ekso Bionics Heartware International, Inc Iwalk, Inc. Jarvik Heart, Inc. SynCardia Systems, LLC Gambro AB Orthofix Holdings LifeNet Health Sonova BionX Medical Technologies Cochlear Baxter International SynCardia Berlin Heart GmbH Nipro Corporation Ottobock Recent Developments1. In February 2020, Ekso Bionics Holdings, Inc. collaborated with Kindred Healthcare, LLC to pilot EksoNR – a robotic exoskeleton, in their long-term acute ...
4/8/2021 Worldwide End Stage Renal Disease Industry to 2025 - High Focus on Technology Presents Opportunities - ResearchAndMarkets.com Yahoo News The "Global End Stage Renal Disease Market (2020-2025) by Disease Type, Treatment Type, End User, Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.The global end stage renal disease market is estimated to be USD 73.1 billion in 2020 and is expected to reach USD 137.08 billion by 2025, growing at a CAGR of 13.4 %.The increasing number of patients suffering ...
4/8/2021 Worldwide End Stage Renal Disease Industry to 2025 - High Focus on Technology Presents Opportunities - ResearchAndMarkets.com | Business Wire Business Wire ... the end stage renal disease (ESRD) market. The ongoing Covid-19 pandemic has resulted in an increased demand for home dialysis across the globe.Companies MentionedNipro Corporation Fresenius Medical Care AG & Co. KGaA Baxter International , Inc. Medtronic Plc B. Braun Melsungen AG BD Asahi Kasei Medical Co., Ltd. Cantel Medical Nikkiso Co., Ltd. JMS Co. Ltd. Abbott Amgen Inc. AstraZeneca Bristol-Myers Squibb Company F. Hoffmann-La Roche Ltd ...
4/3/2021 Regenerative Medicine Market Competitive Landscape and Demand with Clinical Outlook 2021 to 2030 PRSync ... growth.Access Full Description of this report at:-https://www.nextmsc.com/report/regenerative-medicine-marketTop Companies: Integra Lifesciences Corporation, AbbVie Inc., Merck KGaA, Medtronic, Thermo Fisher Scientific Inc., Smith+Nephew, Becton, Dickinson and Company, Baxter International Inc, Cook Biotech, and Organogenesis Inc and others.Based on product type, the market is segmented into cell therapy, gene therapy, tissue engineering, and small molecules & biologics. Based on material, the market is divided ...
4/3/2021 marché Connecteurs IV sans aiguille mondial 2021 tenant compte de l’analyse de l’épidémie de COVID-19 par acteurs clefs Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, CareFusion Corporation, ICU Medical Inc. linstant-interview.com ... Clinic, OthersObtenez 10 % de personnalisation sur ce Rapport d’étude https://www.cognitivemarketresearch.com/medical-devices–consumables/needle-free-iv-connectors-market-report download_reportActeurs clefs du Connecteurs IV sans aiguille du Marché : Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, CareFusion Corporation, ICU Medical Inc., Nexus Medical LLC, RyMed Technologies LLC, Vygon SA //www.cognitivemarketresearch.com/medical-devices–consumables/needle-free-iv-connectors-market-report download_report ...
4/2/2021 Injectable Drug Delivery Market Future Insights : Pfizer and Baxter International, Inc., Gerresheimer AG, Schott AG, Alkermes Plc., Eli Lilly and Company fnbherald.com 2 Injectable Drug Delivery Market Future Insights : Pfizer and Baxter International, Inc., Gerresheimer AG, Schott AG, Alkermes Plc., Eli Lilly and Company Injectable Drug Delivery Market Future Insights : Pfizer and Baxter International, Inc., Gerresheimer AG, Schott AG, Alkermes Plc., Eli Lilly and Company [email protected] Injectable Drug Delivery , Injectable Drug Delivery MarketThis study offers a comprehensive, 360 degree analysis on the Injectable Drug Delivery market, bringing to fore insights ...
4/1/2021 Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE), Quidel (QDEL) and Repare Therapeutics (RPTX) markets.co ... 111.01.According to TipRanks.com , Keusch is a 4-star analyst with an average return of 7.8% and a 69.4% success rate. Keusch covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Baxter International , and Intuitive Surgical.Currently, the analyst consensus on Haemonetics is a Strong Buy with an average price target of $155.83.See today’s analyst top recommended stocks
Quidel (QDEL)Raymond James analyst Andrew Cooper ...
4/1/2021 The Infection Surveillance Solutions Market To Resonate With Growth Between 2025 PRSync The Infection Surveillance Solutions Market To Resonate With Growth Between 2025 persistencemarketresearch - Thursday, April 1, 2021.Infection surveillance solution helps healthcare facilities in reporting patient-associated data to the state and federal authorities. Integration of infection surveillance software with already existing networks of medical facilities and hospitals is an easy process.A recent report published by Persistence Market Research (PMR) estimates the global infection surveillance solution market to register a ...
3/31/2021 Vital organs support systems and Medical Bionics Market In-Depth Analysis & Marginal Revenue Growth 2020-2025 sunrisenigeria.com Vital organs support systems and Medical Bionics Market In-Depth Analysis & Marginal Revenue Growth 2020-2025 3 hours ago craigAMA Research added a comprehensive research document of 200+ pages on ‘Vital organs support systems and Medical Bionics’market with detailed insights on growth factors and strategies. The study segments key regions that includes North America, Europe, Asia-Pacific with country level break-up and provide volume and value related cross ...
3/30/2021 Blood Plasma Market 2020: Potential growth, attractive valuation make it is a long-term investment | Know the COVID19 Impact | Top Players: Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, etc. | InForGrowth chelanpress.com ... key stakeholders of the Blood Plasma market. Some of the leading players profiled in the report include: Allmed Medical Care Holdings Limited Asahi Kasei Corporation. Braun Melsungen AG Bain Medical Equipment (Guangzhou) Co., Ltd. Baxter International Inc. Chengdu OCI Medical Devices Co., Ltd. China Chengdu Wesley Biotech Co., Ltd. FARMASOL Medical Products Ind. and Trd. Co. Fresenius Medical Care AG & Co. KGaA Jiangsu Lengthen Life Science and Technology Co., Ltd ...
3/29/2021 Baxter Launches Initiative to Increase Awareness and Education in Black Communities About Kidney Health and Managing Chronic Kidney Disease Business Wire ... and driving results to achieve meaningful, sustainable change within and beyond Baxter. The partnership between Baxter and The Links and NKFI follows the recent announcement of a three-year, $2 million partnership between the Baxter International Foundation and the American Diabetes Association® (ADA) as part of the ADA’s Health Equity Now (HEN) platform. The community-based program will focus on nutrition and technology as key drivers in removing ...
3/29/2021 Baxter Launches Initiative to Increase Awareness and Education in Black Communities About Kidney Health and Managing Chronic Kidney Disease | Business Wire Business Wire DEERFIELD, Ill. & WASHINGTON- Baxter International Inc. (NYSE:BAX), a leading global medical products company, and the Central Area of The Links, Incorporated, an international not-for-profit comprised of 16,000 women of color, announce a new partnership to bring awareness and resources to the disproportionate challenges affecting Black Americans related to kidney health. Through the partnership, Baxter is committing $600,000 to fund grants to local Links chapters in the organization ...